Mechanistic insights of epithelial protein lost in neoplasm in prostate cancer metastasis

Ross J. Collins, Liam D. Morgan, Sioned Owen, Fiona Ruge, Wen G. Jiang, Andrew J. Sanders*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

EPLIN is frequently downregulated or lost in various cancers. The purpose of this study was to evaluate the importance of EPLIN in prostate cancer progression, with particular focus on the mechanistic implications to elucidate EPLIN's tumor suppressive function in cancer. EPLIN expression was evaluated in prostate cancer cell lines and tissues. PC-3 and LNCaP EPLIN alpha overexpression models were generated through transfection with EPLIN alpha sequence and EPLIN knockdown was achieved using shRNA in CA-HPV-10 cells. Functional assays were performed to evaluate cellular characteristics and potential mechanisms were evaluated using a protein microarray, and validated using western blot analysis. EPLIN expression was reduced in clinical prostate cancer sections, including hyperplasia (p

Original languageEnglish
Pages (from-to)2537-2550
Number of pages14
JournalInternational Journal of Cancer
Volume143
Issue number10
DOIs
Publication statusPublished - 15 Nov 2018
Externally publishedYes

Keywords

  • EPLIN
  • prostate cancer
  • metastasis
  • Src
  • FAK
  • FOCAL-ADHESION KINASE
  • REGULATES ACTIN ORGANIZATION
  • TYROSINE PHOSPHORYLATION
  • CELL-MIGRATION
  • MESENCHYMAL TRANSITION
  • BREAST-CANCER
  • CROSS-LINKING
  • SRC
  • PAXILLIN

Fingerprint

Dive into the research topics of 'Mechanistic insights of epithelial protein lost in neoplasm in prostate cancer metastasis'. Together they form a unique fingerprint.

Cite this